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Introduction: Acute kidney injury (AKI) has high incidence among the critically ill and associates with dismal outcome.
Not only the long-term survival, but also the quality of life (QOL) of patients with AKI is relevant due to substantial
burden of care regarding these patients. We aimed to study the long-term outcome and QOL of patients with AKI
treated in intensive care units.
Methods: We conducted a predefined six-month follow-up of adult intensive care unit (ICU) patients from the
prospective, observational, multi-centre FINNAKI study. We evaluated the QOL of survivors with the EuroQol (EQ-5D)
questionnaire. We included all participating sites with at least 70% rate of QOL measurements in the analysis.
Results: Of the 1,568 study patients, 635 (40.5%, 95% confidence interval (CI) 38.0-43.0%) had AKI according to
the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Of the 635 AKI patients, 224 (35.3%), as
compared to 154/933 (16.5%) patients without AKI, died within six months. Of the 1,190 survivors, 959 (80.6%)
answered the EQ-5D questionnaire at six months. The QOL (median with Interquartile range, IQR) measured with
the EQ-5D index and compared to age- and sex-matched general population was: 0.676 (0.520-1.00) versus 0.826
(0.812-0.859) for AKI patients, and 0.690 (0.533-1.00) versus 0.845 (0.812-0.882) for patients without AKI (P <0.001 in
both). The EQ-5D at the time of ICU admission was available for 774 (80.7%) of the six-month respondents. We
detected a mean increase of 0.017 for non-AKI and of 0.024 for AKI patients in the EQ-5D index (P = 0.728). The
EQ-5D visual analogue scores (median with IQR) of patients with AKI (70 (50–83)) and patients without AKI
(75 (60–87)) were not different from the age- and sex-matched general population (69 (68–73) and 70 (68–77)).
Conclusions: The health-related quality of life of patients with and without AKI was already lower on ICU admission
than that of the age- and sex-matched general population, and did not change significantly during critical illness.
Patients with and without AKI rate their subjective health to be as good as age and sex-matched general population
despite statistically significantly lower QOL indexes measured by EQ-5D.Introduction
Acute kidney injury (AKI) has a high incidence of up to
30% to 40% [1-3] among the critically ill and is associated
with a dismal outcome [3,4]. Almost 40% of patients suf-
fering from severe AKI (KDIGO, Kidney Disease: Improv-
ing Global Outcomes, Stage 3) die within 90 days [3].
Furthermore, only 30% of patients receiving renal replace-
ment therapy (RRT) due to AKI are alive five years after
admission to the ICU [5]. In addition, AKI associates with* Correspondence: sara.nisula@hus.fi
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reproduction in any medium, provided the orpermanently deteriorated kidney function and chronic
dialysis dependency [6]. Despite initial functional recovery,
patients treated with RRT remain at permanent risk of
developing end-stage renal disease [7].
The majority of studies reporting the long-term
survival and health-related quality of life (QOL) of
kidney injury patients focus on RRT patients [5,8,9], but
high mortality and an association with considerable
morbidity is not isolated to the severe stages of AKI.
Only a few long-term outcome and QOL studies focus
on AKI and define AKI with any of the latest consensus
criteria (KDIGO, Acute Kidney Injury Network (AKIN)
or Risk, Injury, Failure, Loss of kidney function and
End-stage kidney disease (RIFLE)). Most of thesetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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group of patients [10-15].
Accordingly, we followed a heterogeneous group of
critically ill patients who were included in the large, pro-
spective observational multi-centre FINNAKI study [3].
In this predetermined sub-study we aimed to evaluate
the six-month survival and QOL of these critically ill
patients and explore factors associated with good QOL
after AKI. We hypothesised that patients with AKI
would have significantly lower QOL compared to those
without AKI and also lower QOL than the age-and sex-
matched general Finnish population.
Materials and methods
Patients
We performed a six-month follow-up of 2,901 ICU
patients included in the prospective, multi-centre FIN-
NAKI study during the period 1 September 2011 to 1
February 2012. In brief, the study included consecutive
emergency ICU patients and elective (postoperative) pa-
tients, whose stay exceeded 24 hours. The FINNAKI
study in detail has been published previously [3]. In this
pre-determined follow-up study we aimed to measure
QOL of all six-month survivors. We decided a priori to
include ICUs with at least a 70% follow-up rate in the
final analysis. Each patient or proxy gave written in-
formed consent for the study. The Ethics Committee
of the Department of Surgery in Helsinki University
Hospital gave approval for the study.
Definitions and data collection of FINNAKI
We measured creatinine (Cr) daily and urine output
hourly and defined AKI with the KDIGO guidelines [16].
If baseline creatinine (latest value from the previous year
excluding the previous week) was not available, we used
the Modification in Diet in Renal Disease (MDRD) equa-
tion assuming a glomerular filtration rate of 75 ml/
1.73 m2 [17]. We collected patient demographics, med-
ical history, severity scores, length-of stay, physiologic
data, and the EuroQol (EQ-5D) questionnaire responses
from the Finnish Intensive Care Consortium prospective
database (Tieto Ltd, Helsinki, Finland) and with a study
specific case report form. We obtained data on survival
at six months from the Finnish Population Register
Centre. We collected physiologic data and screened the
patients for the presence of AKI and severe sepsis for
five days starting from ICU admission.
Health-related quality of life
The QOL of the included patients at ICU admission and
at six months was measured with the EQ-5D [18] ques-
tionnaire. The EQ-5D is a standardized, multidimen-
sional instrument found suitable for critically ill patients
[19,20]. The EQ-5D includes five dimensions (mobility,self-care, usual activities, pain/discomfort, and anxiety/
depression) evaluated on a scale of 1 to 3. Calculating a
single index score (0 to 1) combines these five dimen-
sions. This value can be used in comparisons between
different populations. The questionnaire includes a vis-
ual analogue scale (VAS) (values from 0 to 100) for re-
cording the respondent’s self-rated health. According to
previous reports a significant change in the EQ-5D index
is 0.08, and for the VAS score 7 [21,22]. The ICU nurse
presented the EQ-5D questionnaire to the patient or
proxy when collecting the admission data. Data obtained
from proxies have been shown to be reliable [23,24]. At
six months, the questionnaire was presented by mail or
by telephone.
Statistical analysis
We present continuous data as medians with interquar-
tile ranges (IQR) and absolute values and percentages
with 95% confidence intervals (CI). We used the two-
tailed Mann–Whitney U test or the Kruskal-Wallis test
for comparison of continuous variables and the chi-
square test for categorical variables. We compared the
EQ-5D index and reference values using the Wilcoxon
signed matched pair test. The analysis for the change in
EQ-5D indexes was performed as a paired samples ana-
lysis. We explored potential independent factors associ-
ated with good QOL (defined as at least equal to that of
age- and sex matched controls) at six months. First, we
tested plausible factors in univariable models and, second,
we entered significant variables (P <0.20) into a multivari-
able model (logistic regression). Additional file 1 lists all
the tested and inserted variables. We considered a P value
less than 0.05 as significant unless stated otherwise. We




The study flow chart is presented in Figure 1. Altogether
1,568 patients from ten ICUs with at least a 70% QOL
response rate were included in the final analysis. Charac-
teristics of the study patients are presented in Table 1
and a comparison to the whole FINNAKI study cohort
is in Additional file 2. The incidence of AKI (95% CI) in
this substudy was 635/1,568 (40.5%, 38.0% to 43.0%). Of
all patients (95% CI), 280 (17.9%, 15.9% to 19.8%) had
stage 1, 119 (7.6%, 6.3 to 8.9%) had stage 2, and 236
(15.1%, 13.2% to 16.9%) had stage 3 AKI. During the first
five ICU treatment days 162/1,568 (10.3%, 8.8% to
11.9%) patients received RRT.
Six-month mortality
The overall six-month mortality (95% CI) was 378/1,568
(24.1%, 21.9% to 26.3%). Of the 635 AKI patients, 224
1568 patients in 10 study centers 
84 (20.4%) patients with 
missing EQ-5D at 6 months
327 (79.6%) with EQ-5D at 6 months
635 (40.5%) AKI 933 (59.5%) No AKI
224 (35.3%) dead at 6 months 154 (16.5%) dead at 6 months
411 AKI 779 No AKI
147 (18.9%) patients with 
missing EQ-5D at 6 months
632 (81.1%) with EQ-5D at 6 months
268 (82.0%) with admission EQ-5D 506 (80.1%) with admission EQ-5D 
Figure 1 The study flow chart.
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as compared to 154/933 (16.5%, 95% CI 14.1% to 18.9%)
patients without AKI. The six-month mortality for pa-
tients with RRT was 63/162 (38.9%, 95% CI 31.2% to
46.5%).Health-related quality of life
Of the 1,190 patients who were alive at six months, 959
(80.6%) answered the EQ-5D questionnaire. The median
response time was 232 days. The characteristics of the
respondents and non-respondents at six months were
comparable (data not shown).
Table 2 presents the distribution of the EQ-5D health
questionnaire answers in different patient groups at six
months. The EQ-5D index and VAS at six months after
ICU admission for different patient groups and com-
pared to the age- and sex-matched general population
are presented in Table 3.
Of the six-month respondents (N = 959), the admis-
sion EQ-5D was available for 774 (80.7%). Of these, 615
(79.4%) were answered by the patient, 139 (18.0%) by a
proxy, and in 20 (2.6%) the respondent was unknown. In
these 774 patients the mean increases in the EQ-5D
index during the six-month follow-up were 0.017 (no
AKI) and 0.024 (AKI). The mean difference (95% CI) be-
tween the mean changes for non-AKI and AKI patients
was 0.007 (−0.314 to 0.045) (P = 0.728). The changes in
the EQ-5D index within six months following ICU
admission in different patients groups are illustrated in
Figure 2.Of 1,568 study patients, 390 (24.9%) did not respond
to the EQ-5D questionnaire on ICU admission. These
non-respondents on ICU admission had higher severity
scores compared to the respondents (day 1 SOFA score
(IQR) 8 (6 to 10), as compared to 7 (5 to 9), and SAPS II
score (IQR) 40 (31 to 55), as compared to 35 (26 to 47)).
Of the 378 deceased patients, 223 (59.0%) had res-
ponded to the EQ-5D questionnaire at ICU admission.
The median (IQR) admission EQ-5D index of patients
who died within six months from admission was sig-
nificantly lower (P <0.001) compared to the admission
EQ-5D of those who survived (0.533 (0.356 to 0.690) ver-
sus 0.676 (0.520 to 0788)).
Of the 959 six-month respondents, 311 (32.4%) achieved
a good QOL defined as EQ-5D index which was equal
or superior to that of age- and sex matched general pop-
ulation. Of the 327 AKI patients, 96 (29.4%) achieved
this good QOL. When exploring potential predictors
of good QOL after AKI, we found that (1) the EQ-5D
score at admission (odds ratio (OR) (95% CI) 1.042
(1.024 to 1.060)/0.01 points), and (2) lack of hyperten-
sion (OR 2.561 (1.141 to 5.750) were independent predic-
tors of a good QOL six months after ICU admission. In
non-AKI patients only the admission EQ-5D index (OR
1.039 (1.028 to 1.049)/0.01 points) was an independent
predictor of good QOL at six months. The variables
tested in univariable models and variables inserted into
the multivariable models are listed in Additional file 1.
In this study population a longer hospital length-of stay
(LOS) was associated with lower QOL (P <0.001) [see
Additional file 3].









N (%) or median (IQR) N (%) or median (IQR) N (%) or median (IQR)
Age (years) 1,568 65 (53 to 74) 64 (50 to 73) 66 (56 to 76)
Gender (male) 1,568 1015 (64.7) 583 (62.5) 432 (68.0)
Baseline serum/plasma creatinine (μmol/l) 1,088 78 (63 to 95) 77 (61 to 93) 79 (65 to 101)
Co-morbidity
Chronic obstructive pulmonary disease 1,560 169 (10.8) 91 (9.8) 78 (12.3)
Hypertension 1,567 759 (48.4) 411 (44.1) 348 (54.8)
Arteriosclerosis 1,554 236 (15.1) 116 (12.6) 120 (18.9)
Diabetes 1,568 359 (22.9) 200 (21.4) 159 (25.0)
Systolic heart failure 1,561 219 (14.0) 115 (12.3) 104 (16.5)
Chronic kidney disease 1,562 127 (8.1) 48 (5.1) 79 (12.4)
Admission type
Emergency 1,540 1,287 (82.1) 751 (81.9) 536 (86.0)
Surgical 1,568 618 (39.4) 377 (40.4) 241 (38.0)
APACHE II Diagnostic group
Cardiovascular, operative 355 (22.6) 208 (22.3) 147 (23.2)
Cardiovascular, non-operative 231 (14.7) 121 (13.0) 110 (17.3)
Respiratory tract, non-operative 184 (11.7) 115 (12.3) 69 (10.9)
Gastrointestinal tract, operative 152 (9.7) 86 (9.2) 66 (10.4)
Metabolic 133 (8.5) 93 (10.0) 40 (6.3)
Sepsis 99 (6.3) 43 (4.6) 56 (8.8)
Gastrointestinal tract, non-operative 92 (5.9) 48 (5.1) 44 (6.9)
Neurological, non-operative 85 (5.4) 69 (7.4) 16 (2.5)
Trauma 70 (4.5) 52 (5.6) 18 (2.8)
Other (<5% each) 167 (10.7) 98 (10.5) 69 (10.9)
Severity and outcome
SOFA (first 24 hours, points) 1,568 7 (5 to 10) 6 (4 to 8) 9 (6 to 11)
SAPS II score (points) 1,568 36 (27 to 49) 32 (25 to 43) 42 (33 to 58)
Length of ICU stay (days) 1,568 2.8 (1.6 to 5.4) 2.1 (1.3 to 4.4) 3.8 (2.0 to 7.1)
Length of hospital stay (days) 1,566 9 (5 to 17) 8 (5 to 14) 11 (5 to 19)
Six-month mortality 1,568 378 (24.1) 154 (16.5) 224 (35.3)
APACHE II, Acute Physiology and Chronic Health Evaluation II; SAPS II, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment.
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In this large prospective, multi-centre observational
study in Finnish ICUs we found that two-thirds of the
AKI patients were alive at six months after ICU admis-
sion. The health-related QOL of AKI patients was lower
than that of the age- and sex-matched general popula-
tion, but equal to critically ill patients without AKI.
Six-month mortality
We reported a six-month mortality of 35.3% for AKI pa-
tients, and 16.5% for patients without AKI. The only
previous, prospective study found six-month mortality
of AKI patients (defined by RIFLE, AKIN or KDIGOcriteria) to be 46.5% [13]. In addition, two retrospective,
single-center studies have reported six-month mortality
rates of 58.5% [10] and 38.0% [25] for AKI patients.
The long-term outcome of RRT patients has been
more extensively studied [26]. In our study the six-
month mortality for RRT patients was 38.9%. Three
other ICU studies, all retrospective, have reported higher
six-month mortality rates for RRT patients: 49.4% [27],
59.9% [28], and 74.6% [29].
Health-related quality of life
The QOL of survivors measured six months after ICU
admission did not differ between patients who had
Table 2 EQ-5D (EuroQol) health dimensions at six months after ICU admission
All patients
(N = 959) %
Patients without AKI
(N = 632) %
Patients with AKI
(N = 327) %
Patients with RRT
(N = 85) %
Stage 3 patients
without RRT (N = 29) %
Mobility
I have no problems in walking about 52.3 54.3 48.6 43.5 44.8
I have some problems in walking about 41.0 39.7 43.4 48.2 44.8
I am confined to bed 6.7 6.0 8.0 8.2 10.3
Self-care
I have no problems with self-care 75.9 77.8 72.2 63.5 65.5
I have some problems washing or
dressing myself
18.5 16.6 22.0 28.2 24.1
I am unable to wash or dress myself 5.6 5.5 5.8 8.2 10.3
Usual activities (for example, work, study, housework, family or leisure activities)
I have no problems with performing my
usual activities
57.7 59.2 54.7 57.6 55.2
I have some problems with performing
my usual activities
33.2 32.4 34.6 31.8 31.0
I am unable to perform my usual activities 9.2 8.4 10.7 10.6 13.8
Pain/discomfort
I have no pain or discomfort 46.4 47.9 43.4 40.0 48.3
I have moderate pain or discomfort 47.8 46.5 50.2 51.8 44.8
I have extreme pain or discomfort 5.8 5.5 6.4 8.2 6.9
Anxiety/depression
I am not anxious or depressed 71.8 71.0 73.4 72.9 82.8
I am moderately anxious or depressed 25.3 26.3 23.5 25.9 13.8
I am extremely anxious or depressed 2.8 2.7 3.1 1.2 3.4
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QOL did not change during this follow-up period for
either group. However, the QOL of ICU patients was
already significantly lower than that of the age-and
sex-matched general population at the time of ICU ad-
mission and remained so during the follow-up period
(Table 3). Recently, comparable results obtained with aTable 3 The health-related quality of life by the EQ-5D (EuroQ
after ICU admission compared to the age- and sex-matched g
EQ-5D index
Study patients Gen
All study patients (N = 959) 0.690 (0.533-1.00)a 0.84
No AKI patients (N = 632) 0.690 (0.533-1.00)a 0.84
AKI patients (N = 327) 0.676 (0.520-1.00)a 0.82
Stage 1 (N = 148) 0.691 (0.534-1.00)a 0.82
Stage 2 (N = 65) 0.631 (0.442-0.795)a 0.82
Stage 3 (N = 114) 0.676 (0.486-1.00)a 0.84
With RRT (of stage 3) (N = 85) 0.676 (0.482-0.802)a 0.84
Without RRT (of stage 3) (N = 29) 0.676 (0.504-1.00) 0.82
aP <0.001, comparison between the study patients and the age- and sex-matched g
Values are presented as median (interquartile range, IQR). AKI, acute kidney injury (
replacement therapy.different QOL questionnaire were reported by Hofhuis
et al. [13]. In contrast, in another study from 2009,
AKI patients had a lower QOL six months after sur-
gery compared to patients without AKI [25].
Other QOL studies in AKI patients have only included
RRT patients, and all have reported impaired health
compared to controls [5,27,30-34], in concordance withol) index and visual analogue scale (VAS) at six months
eneral population
EQ-5D VAS
eral population Study patients General population
5 (0.812-0.882) 73 (59–85) 70 (68–77)
5 (0.812-0.882) 75 (60–87) 70 (68–77)
6 (0.812-0.859) 70 (50–83) 69 (68–73)
6 (0.812-0.876) 75 (60–86) 69 (68–76)
6 (0.774-0.859) 69 (50–82) 69 (65–73)
5 (0.826-0.859) 70 (50–80) 70 (68–73)
5 (0.819-0.882) 65 (50–80)a 70 (68–77)
6 (0.826-0.852) 70 (50–90) 68 (68–73)
eneral population.
by the Kidney Disease Improving Global Outcomes, KDIGO criteria); RRT, renal
Figure 2 Boxplot of the changes in the EQ-5D index during six months from ICU admission stratified into different patients groups.
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different intensities of RRT reported low QOL scores for
RRT patients at 60 days [6]. Compared to our study,
however, that study had a different QOL measure
(Health Utilities Index (HUI) versus EQ-5D), follow-up
time (60 days versus 180 days), patient population (only
RRT versus all AKI patients) and reported no admission
QOL data or VAS scores. Two Finnish studies with the
same QOL questionnaire used in our study (EQ-5D) also
reported that the QOL of RRT patients was lower com-
pared to the matched general population [5,27].
RRT patients, despite their impaired QOL, have self-
rated their quality of life as equal to that of the age- and
sex-matched general population [5,27] or stated that
they would choose to undergo the same treatment again
[30,32]. It has been suggested that surviving critical ill-
ness affects how people value their life and they are,
therefore, content with health, which by objective mea-
sures is lower than that of the general population. In our
study, AKI patients were as content with their QOL as
the general population, and ICU patients without AKI
evaluated their QOL to be even better compared to the
general population by VAS. RRT patients, however, re-
ported significantly lower VAS scores compared to the
general population (Table 3).
The QOL of AKI and non-AKI patients was signifi-
cantly lower than that of the general population already
at the time of ICU admission which is in concordance
with previous data [35]. In addition, the change in QOL
in survivors of critical illness was minimal. This indicatesthat critical illness per se may not impact the QOL, but
patients who get critically ill have existing poor health.
Furthermore, patients who died during critical illness
had a significantly lower EQ-5D at ICU admission com-
pared to patients who survived.
One third of the survivors and one third of the AKI
patients had an equal or superior QOL compared to the
age- and sex-matched general population at six months.
We found only two independent predictors of good
QOL at six months after AKI: a higher EQ-5D index at
ICU admission was associated with a higher probability
of a good QOL and lack of hypertension as a chronic
condition added the probability of a good QOL. Surpris-
ingly, age, chronic conditions other than hypertension,
or events prior to ICU admission were not associated
with the QOL outcome at six months in AKI patients.
For comparison, in non-AKI patients only the EQ-5D
index at admission was an independent predictor of a
good QOL at six months in this study population. Ac-
cording to a systematic review from 2005, older age and
increasing severity of illness may be associated with
poorer outcome in some QOL dimensions in EQ-5D
(physical function and general health perception) [35].
In our population, the patients with the highest tertile of
LOS had the lowest QOL at six months in agreement
with one previous study [6]. The systematic review from
2005, however, found no association between ICU LOS
and QOL [35]. Furthermore, hospital LOS is a non-
normally distributed factor that is also affected by factors
unrelated to the patient. These findings reflect the
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us predict which patients will have a favorable outcome
in the form of a good QOL after ICU treatment.
Limitations and strengths
Our study has some limitations. First, although the mor-
tality data at six months were anticipated to be complete
due to the national registry, we expected that QOL data
would be incomplete in some sites. Thus, to provide a
reliable analysis we decided to include only those sites
with at least a 70% QOL response rate. This decision re-
sulted in the exclusion of 7 of 17 sites. Second, only 80%
of those patients who survived in the included ten sites
answered the EQ-5D questionnaire at six months. Finally,
the pre-admission QOL was not available for 19% of six-
month respondents. Thus, our analysis of QOL change
between these two time-points was not complete. How-
ever, of the patients without AKI, one could assume that
those patients who responded were slightly less ill than
those who did not respond. In fact, that was the case and,
thus, our finding of a non-significant difference of mean
changes of QOL in critically ill patients with AKI and
without AKI seems to be more reliable.
An obvious strength of our study is the prospective,
multi-centre design and consecutive inclusion of a large
number of patients both with and without AKI in the
same ICUs and the availability of admission QOL data.
In addition, we aimed to explore carefully the inevitable
selection bias commonly seen in QOL studies in the
critical care setting.
Conclusions
We conclude that two thirds of critically ill AKI patients
survive up to six months after ICU admission. Contrast-
ing with our hypothesis, the six-month QOL of surviving
AKI patients was comparable to that of surviving critic-
ally ill patients without AKI. The QOL of ICU patients
was already lower at the time of ICU admission than
that of the age- and sex-matched general population and
was preserved in surviving patients. However, the per-
ceived QOL of six-month-survivors was comparable to
that of the age- and sex-matched general population
with the exception of RRT patients.
Key messages
 Two thirds of critically ill AKI patients survived up
to six months after ICU admission.
 The six-month health-related quality of life of sur-
viving AKI patients was comparable to that of sur-
viving critically ill patients without AKI.
 The health-related quality of life of patients with
and without AKI was already lower on ICU admis-
sion than that of the age- and sex-matched generalpopulation and did not change significantly during
critical illness.
 AKI patients rated their subjective health to be as
good as the age and sex-matched general population
despite statistically significantly lower indexes mea-
sured by EQ-5D.
Additional files
Additional file 1: Variables tested in univariable models and
variables inserted into the multivariable models for predicting a
good quality of life (equal or superior to age- and sex-matched con-
trols) in patients with and without acute kidney injury.
Additional file 2: Comparison of characteristics of patients in this
study and patients in the FINNAKI study.
Additional file 3: EQ-5D index at six months stratified into groups
based on hospital length-of stay.
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